Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity

Simple item page
dc.contributor.authorDurdagi, Serdaren_US
dc.contributor.authorRandall, Trevoren_US
dc.contributor.authorDuff, Henry Jen_US
dc.contributor.authorChamberlin, Adamen_US
dc.contributor.authorNoskov, Sergei Yen_US
dc.date.accessioned2014-06-12T19:59:52Z
dc.date.available2014-06-12T19:59:52Z
dc.date.issued2014-03-08
dc.descriptionArticle deposited according to publisher policies: http://www.biomedcentral.com/about/copyright June 12, 2014en_US
dc.description.refereedYesen_US
dc.description.sponsorshipFunding provided by the Open Access Authors Funden_US
dc.identifier.citationDurdagi et al.: Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity. BMC Pharmacology and Toxicology 2014 15:14. doi:10.1186/2050-6511-15-14en_US
dc.identifier.doihttp://dx.doi.org/10.11575/PRISM/35116
dc.identifier.urihttp://hdl.handle.net/1880/50021
dc.language.isoengen_US
dc.publisherBioMed Centralen_US
dc.publisher.corporateUniversity of Calgaryen_US
dc.publisher.facultyScienceen_US
dc.publisher.urlhttp://www.biomedcentral.com/2050-6511/15/14en_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleRehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activityen_US
dc.typejournal article
thesis.degree.disciplineBiological Sciencesen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
2014_BMCPharmacologyAndToxicology_Durdagi.pdf
Size:
1.5 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.84 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Science Research & Publications